Invention Grant
- Patent Title: Sanglifehrin based compounds
- Patent Title (中): 基于Sanglifehrin的化合物
-
Application No.: US13575212Application Date: 2011-02-09
-
Publication No.: US09119853B2Publication Date: 2015-09-01
- Inventor: Steven James Moss , Matthew Alan Gregory , Barrie Wilkinson , Christine Janet Martin
- Applicant: Steven James Moss , Matthew Alan Gregory , Barrie Wilkinson , Christine Janet Martin
- Applicant Address: SE Lund
- Assignee: Neurovive Pharmaceutical AB
- Current Assignee: Neurovive Pharmaceutical AB
- Current Assignee Address: SE Lund
- Agency: Dann, Dorfman, Herrell & Skillman
- Agent Robert C. Netter, Jr.; Kathleen D. Rigaut
- Priority: GB1002097.2 20100209; GB1006128.1 20100413; GB1101085.7 20110121
- International Application: PCT/GB2011/050236 WO 20110209
- International Announcement: WO2011/098809 WO 20110818
- Main IPC: C07D498/08
- IPC: C07D498/08 ; C07D413/12 ; A61K31/50
Abstract:
There are provided inter alia compounds of formula (I) useful as cyclophilin inhibitors.
Public/Granted literature
- US20120295841A1 Sanglifehrin Based Compounds Public/Granted day:2012-11-22
Information query
